Series B - Enveda Biosciences
Investment Firm
Overview
Enveda Biosciences is a biotechnology company engineering new drugs from plants.
Announced Date
Jun 14, 2024
Closed on Date
Jun 14, 2024
Funding Type
Series B
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
9
Round Details and Background
Enveda Biosciences raised $55000000 on 2024-06-14 in Series B
Enveda Biosciences is a biotechnology company engineering new drugs from plants.
Company Funding History
7
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Dec 21, 2022 |  Series B - Enveda Biosciences | 12 | - | 55.0M |
| Dec 21, 2022 | Debt Financing - Enveda Biosciences | 1 | - | 13.0M |
| Apr 20, 2023 | Series B - Enveda Biosciences | 6 | - | 51.0M |
| Jun 14, 2024 | Series B - Enveda Biosciences | 9 | - | 55.0M |
Recent Activity
There is no recent news or activity for this profile.